Magnetic resonance in the era of molecular imaging of cancer
about
Advance of molecular imaging technology and targeted imaging agent in imaging and therapyDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersMR Imaging Biomarkers in Oncology Clinical TrialsPreparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombusUltrasonic enhancement of drug penetration in solid tumors.Manganese-based MRI contrast agents: past, present and future.Vessel caliber--a potential MRI biomarker of tumour response in clinical trials.SWIFT-CEST: a new MRI method to overcome T₂ shortening caused by PARACEST contrast agentsMagnetic nanoparticles in magnetic resonance imaging and diagnostics.Analytical methods for characterizing magnetic resonance probes.Surgical resection of malignant gliomas-role in optimizing patient outcome.Gadolinium-based contrast agents for magnetic resonance cancer imaging.Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses.Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.Improving Perfusion Measurement in DSC-MR Imaging with Multiecho Information for Arterial Input Function Determination.A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics.Using the magnetosome to model effective gene-based contrast for magnetic resonance imaging.PET-MR imaging using a tri-modality PET/CT-MR system with a dedicated shuttle in clinical routine.Molecular imaging in the era of personalized medicineSelf-assembled polymeric nanoparticles as new, smart contrast agents for cancer early detection using magnetic resonance imaging.MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles.Multiparametric MRI of the breast: A review.Image quality assessment of automatic three-segment MR attenuation correction vs. CT attenuation correction.Magnetic Resonance Imaging, Digital Mammography, and Sonography: Tumor Characteristics and Tumor Biology in Primary Setting.Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging.Sensing lanthanide metal content in biological tissues with magnetic resonance spectroscopy.Discrimination and anatomical mapping of PET-positive lesions: comparison of CT attenuation-corrected PET images with coregistered MR and CT images in the abdomen.Chemical exchange saturation transfer for predicting response to stereotactic radiosurgery in human brain metastasis.Correlations between diffusion-weighted imaging and breast cancer biomarkers.Multimodal Molecular Imaging: Current Status and Future Directions.
P2860
Q26851887-83AA689C-8360-4C36-8DA2-2D151D494D9BQ28235682-9874E249-A40F-4619-9417-5337BD3B3074Q28283802-C6309CF1-A4C1-4684-AEF7-1C96F3FC4774Q30364608-95DC84AE-BFEE-4929-B8AD-772EC3490A82Q30448359-8BD47A95-1CA5-4C80-86E5-FED4CBDAC94CQ30450492-CF40B552-B49B-4C9F-880D-C8B137231686Q30461349-2EE1B7B3-9D6C-4E1E-A346-72AB8927D416Q30651792-F177A914-9009-427F-B7EC-CD5F15FE242DQ34116038-CE9A2D9D-E229-4102-BF5E-2FC59122FBB9Q34185314-D0A8D981-CAE0-4538-9C0F-CD0866BDAAC1Q34280357-7757DA6E-B4BC-4772-BF3B-14C3EB88C3B2Q34324963-6A3718EC-B3D2-4DA0-AB50-6897DA29AC1EQ36555415-31B51CF5-52AA-42F3-A648-801CCFF80631Q36919071-B523C053-11BC-4155-8D54-0923CCAE5491Q37075671-212662F0-3BA5-42F8-9D42-1F397E3B3954Q37099117-17DA75BF-F387-416E-AE72-336A3E7CF1A3Q37619943-68C72B57-86D2-43E3-B9B3-E20BAEA1BC11Q37992579-770AD36E-A6F2-447E-9A37-9B161BB95EA0Q38051064-B79809AE-9886-4755-8A4A-648EEFE5FED7Q38392168-BB4A28C8-223D-4799-B0CB-AD260156B812Q38922451-CA2131E2-C2D1-43F4-9820-6FC8594B2909Q39032223-09E5F017-C584-446C-9B27-3C8F3D99307CQ39262306-DCFEB9AB-0B23-4C8A-AC50-6B99A126A543Q39390258-628027A3-E757-4116-B469-164B7B5CC682Q39426177-EC824BD3-03AA-4078-A74E-2C490E4C9349Q40287508-91F35650-3B28-452B-821E-76D4A16082E5Q41423088-0EB7A5F1-D5D2-40B0-AE7D-AE03E3F0B23CQ42205877-1CA17DE3-3AA2-45EA-B1BC-3BAC477D05C2Q44333871-2D43BD02-9C07-45D0-9606-F0EDF3C13991Q47924923-916CA8A8-1246-43E7-88E1-AB18B71C85B0Q51404328-02995BC2-7537-4E1D-BA2B-8703D1D9E6BEQ55416268-939535E0-4F4B-47EB-90F2-DDE442514DA1
P2860
Magnetic resonance in the era of molecular imaging of cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Magnetic resonance in the era of molecular imaging of cancer
@ast
Magnetic resonance in the era of molecular imaging of cancer
@en
type
label
Magnetic resonance in the era of molecular imaging of cancer
@ast
Magnetic resonance in the era of molecular imaging of cancer
@en
prefLabel
Magnetic resonance in the era of molecular imaging of cancer
@ast
Magnetic resonance in the era of molecular imaging of cancer
@en
P2093
P2860
P1476
Magnetic resonance in the era of molecular imaging of cancer
@en
P2093
C Chad Quarles
H Charles Manning
John C Gore
Kevin W Waddell
Thomas E Yankeelov
P2860
P304
P356
10.1016/J.MRI.2011.02.003
P577
2011-04-27T00:00:00Z